BOEHRINGER INGELHEIM USA CORPORATION
pharmaceutical company focused on innovative therapies for diseases w/o treatment option
The register keeps a separate record of this client for every firm that files for it and every spelling of its name. All 8 of its records are shown together here.
These two are not added together. An organisation lobbying for itself reports its own spending, and the firms it retains report what they were paid; the rules ask the first to include the second, but filings do not always do so and a filing gives no way to tell. Each is shown as reported.
Reported lobbying by year
Filings
| Filing | Filed by | Amount |
|---|---|---|
|
3rd Quarter - Report 3rd Quarter 2026
|
MONUMENT ADVOCACY | $50,000 reported |
|
3rd Quarter - Report 3rd Quarter 2026
|
TARPLIN, DOWNS & YOUNG, LLC | $70,000 reported |
|
3rd Quarter - Report 3rd Quarter 2026
|
BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC | $1,020,000 reported |
|
3rd Quarter - Report 3rd Quarter 2026
|
MANATT, PHELPS, AND PHILLIPS | $20,000 reported |
|
3rd Quarter - Report 3rd Quarter 2026
|
HANCE SCARBOROUGH | $20,000 reported |
|
2nd Quarter - Report 2nd Quarter 2026
|
MANATT, PHELPS, AND PHILLIPS | $20,000 reported |
|
Registration 2nd Quarter 2026
|
MANATT, PHELPS, AND PHILLIPS | — reported |
|
2nd Quarter - Report 2nd Quarter 2026
|
BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC | $710,000 reported |
|
2nd Quarter - Report 2nd Quarter 2026
|
TARPLIN, DOWNS & YOUNG, LLC | $70,000 reported |
|
2nd Quarter - Report 2nd Quarter 2026
|
MONUMENT ADVOCACY | $50,000 reported |
Filed by
Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.
| Firm | Reports | Amount |
|---|---|---|
| BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC In-house | 77 | $58,538,528 |
| TARPLIN, DOWNS & YOUNG, LLC | 25 | $1,740,000 |
| MONUMENT ADVOCACY | 23 | $1,120,000 |
| HANCE SCARBOROUGH | 26 | $520,000 |
| VENABLE LLP | 11 | $380,000 |
| BLUEBIRD STRATEGIES | 4 | $60,000 |
| WEXLER | WALKER, A UNIT OF HILL+KNOWLTON STRATEGIES, LLC | 3 | $60,000 |
| MANATT, PHELPS, AND PHILLIPS | 2 | $40,000 |
Issues lobbied
How many report sections named each issue, counting the current version of each report.
| Issue | Code | Mentions |
|---|---|---|
| Health Issues | HCR | 115 |
| Budget/Appropriations | BUD | 105 |
| Medicare/Medicaid | MMM | 97 |
| Animals | ANI | 83 |
| Agriculture | AGR | 58 |
| Copyright/Patent/Trademark | CPT | 38 |
| Pharmacy | PHA | 37 |
| Trade (domestic/foreign) | TRD | 35 |
| Consumer Issues/Safety/Products | CSP | 21 |
| Defense | DEF | 16 |
| Taxation/Internal Revenue Code | TAX | 12 |
| Accounting | ACC | 8 |
| Tariff (miscellaneous tariff bills) | TAR | 4 |
| Law Enforcement/Crime/Criminal Justice | LAW | 4 |
| Labor Issues/Antitrust/Workplace | LBR | 4 |
Bills named in its filings
Bill numbers found in the filers' descriptions, most often named first.
| Bill | Congress | Times named |
|---|---|---|
| S. 723 | 118th | 21 |
| H.R. 1458 | 118th | 19 |
| S.Con.Res. 3 | 115th | 15 |
| S. 469 | 115th | 12 |
| H.R. 2113 | 116th | 11 |
| H.R. 1319 | 117th | 8 |
| S. 2599 | 117th | 8 |
| H.R. 3 | 117th | 8 |
| H.R. 1706 | 111th | 8 |
| H.R. 1492 | 119th | 7 |
| S. 832 | 119th | 7 |
| H.R. 3419 | 118th | 7 |
| S. 1666 | 118th | 7 |
| H.R. 19 | 117th | 7 |
| S. 296 | 112th | 7 |
| S. 5369 | 111th | 7 |
| H.R. 8467 | 118th | 6 |
| H.R. 4818 | 118th | 6 |
| H.R. 5378 | 118th | 6 |
| S. 2407 | 118th | 6 |
| H.R. 275 | 116th | 6 |
| H.R. 965 | 116th | 6 |
| S. 4134 | 116th | 6 |
| H.R. 107 | 116th | 6 |
| H.R. 1520 | 116th | 6 |
From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.